Vista AI Raises $29.5M Series B with Strategic Backing from Health Systems

Vista AI has announced the close of a $29.5 million Series B financing round as hospitals and health systems increasingly invest in automation to address operational constraints in medical imaging. New investors include Cedars-Sinai Health System, Intermountain Health, University of Utah Hospital System, Temple University/Fox Chase Cancer Center, and Tampa General Hospital, alongside participation from Khosla Ventures, Bold Brain Capital, and existing backers.

The financing comes amid sustained growth in demand for MRI examinations, which has placed pressure on radiology departments facing shortages of experienced technologists. Vista AI’s software automates MRI scanning workflows, with the aim of reducing complexity and variability while enabling consistent image quality across sites.

“Radiology is facing a critical bottleneck: demand for MRI far outstrips the supply of skilled technologists, overburdening staff and forcing delays for patients,” said Daniel Hawkins, CEO of Vista AI. “Vista AI is breaking through that barrier by automating the scanning process, enabling technologists to consistently and efficiently deliver high-quality imaging, regardless of location.”

Vista AI plans to use the new capital to expand beyond its FDA-cleared and commercially available cardiac MRI platform into additional anatomies, including brain, prostate, and spine, pending regulatory clearance. The company is also extending its offering to include remote scanning services, enabling sites without prior cardiac MRI expertise or specialized staffing to deliver advanced imaging exams. Together, these capabilities are intended to form a broader platform for automated MRI scanning across multiple clinical use cases.

The company has reported operational improvements at early adopter sites. At Brigham and Women’s Hospital, Vista AI enabled a 50% increase in available cardiac MRI scan slots, eliminated a 28-day backlog, and supported next-day patient access without additional staff, scanners, or extended operating hours. At Radiology Regional, an imaging provider in Southwest Florida, the platform reduced scan times by more than 50% and supported technologists without prior cardiac MRI experience in delivering exams.

Health system investors highlighted the clinical and operational implications of automation. “Consistency in imaging quality translates directly into better patient care, and we are now able to provide that consistent standard of excellence across our system,” said Maureen Burgess, Partner at Cedars Sinai Health Ventures. Dr. Blake Gardner, Senior Medical Director of the Cardiovascular Clinical Program at Intermountain Health, added, “With demand rising and technologists in short supply, automation is the only way forward. Vista AI can extend advanced imaging beyond our main centers and make MRI accessible to more patients across our network.”

From an investor perspective, the focus has been on infrastructure-level impact. “MRI is the backbone of modern diagnosis, yet access is constrained by workforce shortages and complexity. Vista AI is the only company directly addressing this issue with automation,” said Bruce Armstrong, Partner at Khosla Ventures.

Vista AI has continued to expand its customer base and leadership team over the past year, positioning automated MRI scanning as a scalable response to workforce and access challenges in radiology.

Click here for the original news story.